For medicines authorised through the centralised procedure, the inclusion of the " Blue Box " in the outer label is required. The Regulation provides that an application for the authorisation of a medicinal product for human use should specifically and completely include the particulars and documents as referred in particular in Article 8(3)(j) of Directive 2001/83/EC which provides that: "The application [for a marketing. The State Institute for Drug Control (hereinafter referred to as “SÚKL”) informs about an update to the guidance laying down blue-box requirements that have been updated with a view to legislative amendments and harmonisation of requirements governing medicinal products authorised via. Let us become the World's Leading GMP/GDP Compliance Community in 2026 The so-called " Frequently asked questions about parallel distribution " were updated in April 2022 and published on the EMA website. In July 2021 you could already read about the information provided by the EMA on parallel. The "Guideline on the Packaging Information of medicinal products for human use authorised by the Community" - so called "Blue-Box Guideline für zentralen Zulassungen" can be found on the following website::. Blue Label provides high-quality label printing for medical and recreational cannabis and CBD products, including oils, edibles, and topical products. For a. The MHRA approves all packaging and labelling information for medicines sold in the UK including the information that must be provided.
